Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

News

Sygnature is proud of its many achievements, research collaborations and awards and delighted to publish these achievements wherever possible. Below you can read and hear about exciting new developments within the organization.

Filter by:

News

Sygnature Discovery completes acquisition of SB Drug Discovery to further strengthen its market-leading capabilities

READ ARTICLE

News

Sygnature Discovery partners the Oncology Development Programme (ODP2) to find UK-based breakthroughs in Oncology

READ ARTICLE

News

Sygnature Discovery deploys Iktos’ AI technology ‘Makya™’

READ ARTICLE

News

Sygnature Discovery acquires Peak Proteins

READ ARTICLE

News

Paper on drug discovery equipment

READ ARTICLE

News

500 – and counting!

READ ARTICLE

News

Taking a 3D view of heart failure with River BioMedics

READ ARTICLE

News

Our new Chairman: Dr Charles Woler

READ ARTICLE

News

Sygnature strengthens with MedChemica software solution

READ ARTICLE

News

Expansions, transactions and all action: Our 2021 recap!

READ ARTICLE

News

New CFO Jordison steps up

READ ARTICLE

News

Sygnature collaborates with Japanese bio-venture company Epigeneron

READ ARTICLE
MORE...